SAFE CELL REPORTER SYSTEM FOR SEARCHING FOR NUCLEOSIDE AND NON-NUCLEOSIDE INHIBITORS OF RNA-DEPENDENT RNA-POLYMERASE SARS-CoV-2
2024-01-25
专利权人ENGELHARDT INST MOLECULAR BIOLOGY (ENGE-Non-standard)
申请日期2024-01-25
专利号RU2836343-C1
成果简介NOVELTY - Invention relates to molecular biology, medicinal chemistry, virology and microbiology and is intended for screening of potential inhibitors of RNA-dependent RNA-polymerase (RDRP) SARS-CoV-2 in laboratories with the first level of biosaur, not equipped for work with highly pathogenic infections. More specifically, the invention relates to full-size replicons, that is artificially created systems which enable to test potential inhibitors of SARS-CoV-2 RDRP without using high-grade viral particles. As a safe cell system for testing inhibitors of RNA-dependent RNA polymerase SARS-CoV-2, a genetic construct is obtained, which is a cDNA of a virus, which does not contain genes of structural proteins S, E and M, with two blocks of reporter genes, which is cloned into an artificial bacterial chromosome vector. First reporter gene unit, represented by Renilla reniformis luciferase and green fluorescent protein (Rluc-GFP), is under the control of the CMV promoter located in front of 5'UTR SARS-CoV-2. Second reporter gene unit is represented by firefly luciferase Photinus pyralis and red fluorescent protein (Fluc-RFP) and is located after the transcription control sequence (TRS-N). Such arrangement of genes and regulatory sequences (CMV-5'UTR-Rluc-GFP-TRS-N-Fluc-RFP-3'UTR) allows to estimate the level of inhibition of viral RGR, since the second reporter gene unit, located after TRS-N, can be transcribed only by viral polymerase by the intermittent transcription mechanism characteristic of the Coronaviridae family. First block of reporter genes, which is under control of the CMV-promoter, can be transcribed not only by viral RDRP, but also by cellular polymerases. For use as a negative control, a full-length replicon system has been created, in which amino acids (D760A, D761A) are substituted in the active center of the polymerase subunit of RDRP, which lead to loss of catalytic activity of RDRP. USE - Biotechnology. ADVANTAGE - To facilitate the search for nucleoside inhibitors of RDRP without creating phosphorylated depot forms, a cell line Vero E6_TK, which expresses thymidine kinase of herpes simplex virus, which performs the first stage of nucleoside phosphorylation in a cell, is created. 3 cl, 14 dwg, 1 tbl, 8 ex
IPC 分类号C12N-001/00
国家俄罗斯
专业领域生物科学
语种英语
成果类型专利
文献类型科技成果
条目标识符http://119.78.100.226:8889/handle/3KE4DYBR/18349
专题中国科学院新疆生态与地理研究所
作者单位
ENGELHARDT INST MOLECULAR BIOLOGY (ENGE-Non-standard)
推荐引用方式
GB/T 7714
ANISENKO A N,KOROLEV S P,GALKIN S O,et al. SAFE CELL REPORTER SYSTEM FOR SEARCHING FOR NUCLEOSIDE AND NON-NUCLEOSIDE INHIBITORS OF RNA-DEPENDENT RNA-POLYMERASE SARS-CoV-2. RU2836343-C1[P]. 2024.
条目包含的文件
条目无相关文件。
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。